May 08, 2014 9:26am EDT
Download as PDF
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (NYSE: OPK) today announced that on May 5, 2014, the
Eighth Judicial District Court of the State of Nevada in and for the
County of Clark granted the Company's motion to dismiss the securities
class action lawsuit brought against the Company on behalf of the
shareholders of PROLOR Biotech, Inc. in connection with the acquisition
of PROLOR by OPKO. The Court dismissed all claims as to all defendants
including PROLOR and its former officers and directors asserted in the
case without prejudice.
ABOUT OPKO
OPKO is a multinational biopharmaceutical and diagnostics company that
seeks to establish industry leading positions in large, rapidly growing
markets by leveraging its discovery, development and commercialization
expertise and novel and proprietary technologies.
This press release contains "forward-looking statements," as that
term is defined under the Private Securities Litigation Reform Act of
1995 (PSLRA), which statements may be identified by words such as
"expects," "plans," "projects," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates," and other words of similar
meaning, including all non-historical statements about our expectations,
beliefs or intentions regarding our business, technologies and products,
financial condition, strategies, prospects, growth opportunities, and
management. Many factors could cause our actual activities or results to
differ materially from the activities and results anticipated in
forward-looking statements. These factors include those described in our
filings with the Securities and Exchange Commission, and risks inherent
in funding, developing and obtaining regulatory approvals of new,
commercially-viable and competitive products and treatments. In
addition, forward-looking statements may also be adversely affected by
general market factors, competitive product development, product
availability, federal and state regulations and legislation, the
regulatory process for new products and indications, manufacturing
issues that may arise, patent positions and litigation, among other
factors. The forward-looking statements contained in this press release
speak only as of the date the statements were made, and, except as
required by applicable law, we do not undertake any obligation to update
forward-looking statements. We intend that all forward-looking
statements be subject to the safe-harbor provisions of the PSLRA.
OPKO Health, Inc.
Steven D. Rubin or Adam Logal,
Source: OPKO Health, Inc.
Released May 8, 2014
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page